Assessing Depression in a Geriatric Cancer Population

Breast Cancer Clinical Trial

Official title:

Assessing Depression in a Geriatric Cancer Population

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00580476
• Other study ID #: 06-100
• Status: Active, not recruiting
• Start date: September 2006
• Est. completion date: June 10, 2025

Study information

• Verified date: January 2024
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this study is to learn more about how we measure depression in elderly cancer patients (patients aged 70 and older). Depression is one of the most common causes of emotional distress in the elderly and continues to be under-recognized. This is a problem because depression can have a negative impact on quality of life. The symptoms of depression are linked to poor health outcomes and higher costs of health care. In fact, depression is one of the top five concerns facing the elderly today.

Description:

We have a few questionnaires that have been used to measure depression, but we do not know how these measures work with people with cancer. This study will help us answer this question. To complete this study, we need people who may or may not be feeling down or depressed.

If you choose to take part, you will be asked to do the following:

1. Fill out questionnaires that ask about:

• Your age, eduction, race, and income

• Your mood

In all, these questionnaires will take about 10 minutes to complete.

2. Answer questions about your mood. This will also take about 10 minutes to complete.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 201
• Est. completion date: June 10, 2025
• Est. primary completion date: June 10, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

1. Age 70 and older

2. Diagnosis of early or late stage prostate cancer, or diagnosis of early or late stage breast cancer

3. Actively engaged in one of the following cancer treatments: chemotherapy, radiation therapy, hormone therapy

4. Able to provide informed consent

5. Ability to converse, write and read English

Exclusion Criteria:

1.Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.

Related Conditions & MeSH terms

• Breast Cancer
• Prostate Cancer
• Prostatic Neoplasms

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	City of Hope National Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Test the sensitivity and specificity of the Geriatric Depression Scale-Short Form and two other widely used assessments of depression to detect major and minor depression in a geriatric breast and prostate cancer population.		2 years
Secondary	To develop a cut-off score for the GDS that is specific to a cancer population.		2 years

External Links

•   Memorial Sloan Kettering Cancer Center